LU91087I2 - Advate(Octocog alfa) soustotes ses formes protégées par le brevet de base. - Google Patents
Advate(Octocog alfa) soustotes ses formes protégées par le brevet de base.Info
- Publication number
- LU91087I2 LU91087I2 LU91087C LU91087C LU91087I2 LU 91087 I2 LU91087 I2 LU 91087I2 LU 91087 C LU91087 C LU 91087C LU 91087 C LU91087 C LU 91087C LU 91087 I2 LU91087 I2 LU 91087I2
- Authority
- LU
- Luxembourg
- Prior art keywords
- protein
- factor viiic
- compsn
- polypeptide
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/570,062 US5004804A (en) | 1984-01-12 | 1984-01-12 | Method and composition for preparation of factor VIIIC |
US66491984A | 1984-10-26 | 1984-10-26 | |
EP85100223A EP0150735B2 (fr) | 1984-01-12 | 1985-01-11 | Composition protéique à activité coagulante et méthode de préparation de ladite composition |
Publications (1)
Publication Number | Publication Date |
---|---|
LU91087I2 true LU91087I2 (fr) | 2004-08-26 |
Family
ID=27075219
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU91014C LU91014I2 (fr) | 1984-01-12 | 2003-03-18 | Kogentate (Octocog alfa) dans toutes ses formes couvertes par le brevet de base |
LU91013C LU91013I2 (fr) | 1984-01-12 | 2003-03-18 | ReFacto (Moroctocog alfa) dans toutes ses formes couvertes par le brevet de base |
LU91015C LU91015I2 (fr) | 1984-01-12 | 2003-03-18 | Recombinate (Rurioctocog alfa) dans toutes ses formes couvertes par le brevet de base |
LU91087C LU91087I2 (fr) | 1984-01-12 | 2004-06-26 | Advate(Octocog alfa) soustotes ses formes protégées par le brevet de base. |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU91014C LU91014I2 (fr) | 1984-01-12 | 2003-03-18 | Kogentate (Octocog alfa) dans toutes ses formes couvertes par le brevet de base |
LU91013C LU91013I2 (fr) | 1984-01-12 | 2003-03-18 | ReFacto (Moroctocog alfa) dans toutes ses formes couvertes par le brevet de base |
LU91015C LU91015I2 (fr) | 1984-01-12 | 2003-03-18 | Recombinate (Rurioctocog alfa) dans toutes ses formes couvertes par le brevet de base |
Country Status (7)
Country | Link |
---|---|
EP (3) | EP0150735B2 (fr) |
JP (5) | JPH0826078B2 (fr) |
AT (2) | ATE78871T1 (fr) |
DE (6) | DE10399009I1 (fr) |
DK (3) | DK165506C (fr) |
LU (4) | LU91014I2 (fr) |
NL (4) | NL300118I2 (fr) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4657894A (en) * | 1983-03-31 | 1987-04-14 | Scripps Clinic & Research Foundation | New factor VIII coagulant polypeptides |
JPH07106156B2 (ja) * | 1983-10-28 | 1995-11-15 | ジェネティックス、インスティチュ−ト | ファクタ−▲viii▼および関連生産物の製造 |
US7138505B1 (en) | 1984-01-12 | 2006-11-21 | Novartis Vaccines And Diagnostics, Inc. | Factor VIII:C nucleic acid molecules |
ZA852099B (en) * | 1984-03-26 | 1985-12-24 | Meloy Lab | Recombinant factor viii-c. |
IL74909A (en) * | 1984-04-20 | 1992-01-15 | Genentech Inc | Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein |
US4965199A (en) * | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
EP0182448A3 (fr) * | 1984-08-24 | 1987-10-28 | Genetics Institute, Inc. | Production de facteur VIII et produits apparentés |
SE8501050D0 (sv) * | 1985-03-05 | 1985-03-05 | Kabivitrum Ab | Biologically active fragments of human antihemophilic factor and method for preparation thereof |
ES8801674A1 (es) * | 1985-04-12 | 1988-02-16 | Genetics Inst | Un procedimiento para la preparacion de una proteina que presenta actividad procoagulante. |
KR910006424B1 (ko) * | 1985-08-21 | 1991-08-24 | 인코텍스 비.브이 | 편성브리프(brief) 제조방법 |
US5198349A (en) * | 1986-01-03 | 1993-03-30 | Genetics Institute, Inc. | Method for producing factor VIII:C and analogs |
FI98829C (fi) * | 1986-01-27 | 1997-08-25 | Chiron Corp | Menetelmä rekombinoidun proteiinikompleksin valmistamiseksi, jolla on humaanitekijä VIII:C-aktiivisuutta |
US5595886A (en) * | 1986-01-27 | 1997-01-21 | Chiron Corporation | Protein complexes having Factor VIII:C activity and production thereof |
EP0251843A1 (fr) * | 1986-06-06 | 1988-01-07 | Transgene S.A. | Procédé de préparation de facteur VIII à partir de cellules de mammifères |
WO1988000210A1 (fr) * | 1986-06-24 | 1988-01-14 | Nordisk Gentofte A/S | Procede pour produire un complexe actif de coagulation des fragments du facteur viii |
EP0254076B1 (fr) | 1986-07-11 | 1991-05-08 | Miles Inc. | Protéine recombinante |
NO872932L (no) * | 1986-07-18 | 1988-01-19 | Gist Brocades Nv | Fremgangsmaate for fremstilling av proteiner med faktorviiiaktivitet ved hjelp av mikrobielle vertsceller, eksprimeringsvektorer, vertsceller, antibiotika. |
IL84168A0 (en) * | 1986-10-15 | 1988-03-31 | Rorer Int Overseas | Human factor viii-c analogs,process for the preparation thereof and pharmaceutical compositions containing the same |
JP2872255B2 (ja) * | 1987-01-30 | 1999-03-17 | バイオジエン,インコーポレイティド | ファクター▲viii▼の高収量生産法 |
CA1339946C (fr) * | 1987-03-31 | 1998-07-07 | Michael J. Griffith | Methode d'ultrapurification pour les polypeptides |
EP0294910B1 (fr) | 1987-06-12 | 1996-09-11 | Immuno Ag | Protéines à activité de facteur VIII, procédé pour leur production utilisant des cellules modifiées par génie génétique et compositions pharmaceutiques les contenant |
DE3737239A1 (de) * | 1987-11-03 | 1989-10-12 | Behringwerke Ag | Gentechnische herstellung von anticoagulatorischem protein pp4 |
US6140111A (en) * | 1987-12-11 | 2000-10-31 | Whitehead Institute For Biomedical Research | Retroviral gene therapy vectors and therapeutic methods based thereon |
US6544771B1 (en) * | 1987-12-11 | 2003-04-08 | Cell Genesys, Inc. | Retroviral gene therapy vectors and therapeutic methods based thereon |
WO1991004059A2 (fr) * | 1989-09-14 | 1991-04-04 | Baxter International Inc. | Procede et appareil utile de preparation de compositions pharmaceutiques |
US5610033A (en) * | 1990-04-25 | 1997-03-11 | Novo Nordisk A/S | Method of producing proteins with FVIII activity and/or FVIII derivatives |
DK53792D0 (da) * | 1992-04-24 | 1992-04-24 | Novo Nordisk As | Fremgangsmaade til fremstilling af proteiner |
US5910481A (en) * | 1995-11-13 | 1999-06-08 | Immuno Ag | Hybrid proteins with modified activity |
EP0965597A4 (fr) * | 1996-12-27 | 2003-01-08 | Mochida Pharm Co Ltd | Medicaments diriges vers la membrane cellulaire |
RU2244556C2 (ru) | 1999-02-22 | 2005-01-20 | Юниверсити Оф Коннектикут | Новые не содержащие альбумин составы фактора viii |
EP1418810A4 (fr) | 2001-08-03 | 2006-08-02 | Us Gov Health & Human Serv | Traitement de l'hemophilie par voie orale |
US7718787B2 (en) * | 2002-10-18 | 2010-05-18 | Lg Life Sciences Limited | Gene families associated with cancers |
EP1707634A1 (fr) | 2005-03-29 | 2006-10-04 | Octapharma AG | Procédé pour l'isolation de protéines recombinantes |
EP1739179A1 (fr) | 2005-06-30 | 2007-01-03 | Octapharma AG | Transfection stable exempt de sérum et production des protéines recombinantes humaines dans des lignées cellulaires humaines |
JP5779780B2 (ja) | 2008-11-07 | 2015-09-16 | バクスター・インターナショナル・インコーポレイテッドBaxter International Incorp0Rated | 第viii因子製剤 |
WO2011095604A1 (fr) | 2010-02-04 | 2011-08-11 | Octapharma Biopharmaceuticals Gmbh | Prolongation de la demi-vie de protéines |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4657894A (en) * | 1983-03-31 | 1987-04-14 | Scripps Clinic & Research Foundation | New factor VIII coagulant polypeptides |
CA1341506C (fr) * | 1983-03-31 | 2006-06-06 | Theodore S. Zimmerman | Polypeptides coagulants analogues au facteur viii ainsi que des anticorps monoclonaux que leur sont specifiques |
US4663280A (en) * | 1983-05-19 | 1987-05-05 | Public Health Research Institute Of The City Of New York | Expression and secretion vectors and method of constructing vectors |
JPH07106156B2 (ja) * | 1983-10-28 | 1995-11-15 | ジェネティックス、インスティチュ−ト | ファクタ−▲viii▼および関連生産物の製造 |
ZA852099B (en) * | 1984-03-26 | 1985-12-24 | Meloy Lab | Recombinant factor viii-c. |
IL74909A (en) * | 1984-04-20 | 1992-01-15 | Genentech Inc | Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein |
JPH0634760A (ja) * | 1992-07-15 | 1994-02-10 | Hamamatsu Photonics Kk | 放射線計測装置及び核医学診断装置 |
-
1985
- 1985-01-11 AT AT85100223T patent/ATE78871T1/de not_active IP Right Cessation
- 1985-01-11 AT AT91113267T patent/ATE224445T1/de active
- 1985-01-11 DE DE2003199009 patent/DE10399009I1/de active Pending
- 1985-01-11 DE DE3588242T patent/DE3588242T2/de not_active Expired - Lifetime
- 1985-01-11 DE DE2003199010 patent/DE10399010I1/de active Pending
- 1985-01-11 DE DE200412000028 patent/DE122004000028I1/de active Pending
- 1985-01-11 EP EP85100223A patent/EP0150735B2/fr not_active Expired - Lifetime
- 1985-01-11 JP JP60002269A patent/JPH0826078B2/ja not_active Expired - Lifetime
- 1985-01-11 DE DE2003199011 patent/DE10399011I1/de active Pending
- 1985-01-11 DE DE3586402T patent/DE3586402T3/de not_active Expired - Lifetime
- 1985-01-11 EP EP91113267A patent/EP0466199B1/fr not_active Revoked
- 1985-01-11 DK DK013585A patent/DK165506C/da not_active IP Right Cessation
- 1985-01-11 EP EP00200860A patent/EP1006182A3/fr not_active Ceased
-
1991
- 1991-04-15 JP JP3082573A patent/JPH0634760B2/ja not_active Expired - Lifetime
-
1992
- 1992-03-25 DK DK038892A patent/DK169708B1/da not_active IP Right Cessation
- 1992-12-17 DK DK150992A patent/DK169724B1/da not_active IP Right Cessation
-
1993
- 1993-04-20 JP JP5092775A patent/JPH06105688A/ja active Pending
-
1999
- 1999-06-07 JP JP11160290A patent/JP2000023670A/ja active Pending
-
2001
- 2001-09-26 JP JP2001295193A patent/JP2002186487A/ja active Pending
-
2003
- 2003-03-18 NL NL300118C patent/NL300118I2/nl unknown
- 2003-03-18 LU LU91014C patent/LU91014I2/fr unknown
- 2003-03-18 LU LU91013C patent/LU91013I2/fr unknown
- 2003-03-18 LU LU91015C patent/LU91015I2/fr unknown
- 2003-03-18 NL NL300120C patent/NL300120I1/nl unknown
- 2003-03-18 NL NL300119C patent/NL300119I1/nl unknown
-
2004
- 2004-06-25 NL NL300153C patent/NL300153I1/nl unknown
- 2004-06-26 LU LU91087C patent/LU91087I2/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU91087I2 (fr) | Advate(Octocog alfa) soustotes ses formes protégées par le brevet de base. | |
BR8606615A (pt) | Polipeptideos complementares a peptideos ou proteinas tendo uma sequencia de aminoacidos ou sequencia de codificacao de nucleotidios conhecida ao menos parcialmente e metodos de projeto dos mesmos | |
DK532284A (da) | Fremgangsmaade til bestemmelse af antigenaktive aminosyresekvenser | |
ATE185350T1 (de) | Synthetische antigene zum nachweis von antikörpern gegen hepatitis c virus | |
ES2184728T3 (es) | Proteinas de union a la fibronectina. | |
DE68925199D1 (de) | Peptide und polypeptide stammend von den submaxillaren drüsen der ratte, deren entsprechende monoklonale und polyklonale antikörper entsprechende hybridomen und verwendung dieser verbindungen in der diagnose bei bestimmungen und für pharmazeutische zwecke | |
FR2660757B1 (fr) | Procede d'identification ou de dosage de proteines et applications. | |
DE3481861D1 (de) | Antigen im zusammenhang mit der fruehzeitigen feststellung von schwangerschaft bei saeugern. | |
ATE197155T1 (de) | Stannius- körperchen -protein, stanniocalcin | |
DE68925043D1 (de) | Synthetische Peptide und deren Mischungen für den Nachweis von HIV-Antikörpern | |
ATE432287T1 (de) | Peptidfragmente mit den zelltod verhindernder aktivität | |
DK0418590T3 (da) | Antistoffer, fremstilling deraf og anvendelse deraf | |
FI943218A (fi) | Kaseinomakropeptidin peptidit, mainittujen peptidien vasta-aineet ja käytöt | |
ATE350398T1 (de) | Protein s polypeptide und deren verwendungen | |
KR950018049A (ko) | 사람 dna 토포이소머라제 제i형의 돌연변이체 단백질 | |
KR890009417A (ko) | 모노크로날 항체의 제조방법 및 그것의 이용방법 |